TMC125-C223: TMC125 in HIV-1 Infected Subjects - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

TMC125-C223: TMC125 in HIV-1 Infected Subjects

This study has been completed.

Study NCT00081978 Information provided by Tibotec Pharmaceuticals, Ireland

First Received: April 28, 2004 Last Updated: April 26, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	October 2005
Estimated Primary Completion Date:	No date given

Publications:

Cohen CJ, Berger DS, Blick G, Grossman HA, Jayaweera DT, Shalit P, Thompson M, Peeters M, de Béthune MP, Voorspoels E, Mack R, Woodfall B. Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial. AIDS. 2009 Jan 28;23(3):423-6.

Back to top of Main Content